19qchromdelbldtql

What is this test?

The 19q chromosome deletion test is a specialized molecular genetics test that looks for the deletion (loss) of genetic material from the long arm (q) of chromosome 19. This test uses advanced laboratory techniques to analyze DNA from your blood or tissue sample. The presence or absence of this deletion provides important information about certain medical conditions, particularly brain tumors.

Why is this test performed?

This test is primarily used to help diagnose and classify brain tumors, especially oligodendrogliomas (a type of glioma). The 19q deletion is found in approximately 50-80% of oligodendrogliomas. When detected along with certain other genetic changes (like 1p deletion), it helps confirm the diagnosis and provides information about how the tumor may behave. Additionally, this genetic marker can help predict how the tumor might respond to certain treatments, particularly chemotherapy.

How is the test done?

A healthcare provider will collect a blood sample from a vein in your arm, or a tissue sample may be obtained through a biopsy or during surgery if a tumor is being evaluated. The sample is then sent to a specialized genetics laboratory where technicians extract the DNA and use molecular techniques to detect whether the 19q region is present or deleted. Results are typically available within a few weeks, as the analysis requires specialized testing.

What do the results mean?

The result is reported as "deletion present" or "deletion not detected." If a 19q deletion is detected in a brain tumor, it supports the diagnosis of oligodendroglioma and is generally associated with a better prognosis. Patients with this deletion often respond better to certain chemotherapy regimens. Your doctor will interpret these results together with other clinical findings, imaging studies, and possibly other genetic tests to make the most accurate diagnosis and treatment plan.